Changes in microglia during drug treatment of stroke

Microglia are the main immune cells in the brain and the first defense barrier of the nervous system. Microglia play a complex role in the process of stroke. A growing number of studies focus on the mechanism of action of drugs functions and how to regulate microglia. Therefore, we talk about the pathophysiological mechanisms of stroke and elaborate on the microglia signaling pathways of drug action in stroke models and how these drugs play a role in stroke treatment in this review. Understanding how drugs modulate proinflammatory and anti‐inflammatory responses of microglia may be critical to implementing therapeutic strategies using immune interventions in stroke.

Abstract licence: CC BY

1. 14.

   Pathophysiology, treatment, and animal and cellular models of human ischemic stroke · 2011

2. 31.

   Celastrol treatment protects against acute ischemic stroke-induced brain injury by promoting an IL-33/ST2 axis-mediated microglia/macrophage M2 polarization · 2018

3. 36.

   The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation · 2018

4. 40.

   Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia/reperfusion injury · 2018

36 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.